- Previous Close
0.0280 - Open
0.0280 - Bid 0.0150 x --
- Ask 0.0315 x --
- Day's Range
0.0280 - 0.0280 - 52 Week Range
0.0008 - 0.0280 - Volume
1,000 - Avg. Volume
72,609 - Market Cap (intraday)
539,425 - Beta (5Y Monthly) 2.00
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0200 - Earnings Date Apr 28, 2025 - May 2, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Lobe Sciences Ltd., a biopharmaceutical company, engages in the research and development using sub-hallucinatory doses of proprietary psychedelic compounds to improve brain and mental health, and wellness in Canada. The company was formerly known as Greenstar Biosciences Corp. and changed its name to Lobe Sciences Ltd. in November 2020. Lobe Sciences Ltd. was founded in 2018 and is headquartered in Vancouver, Canada.
www.lobesciences.comRecent News: LOBEF
View More
Performance Overview: LOBEF
Trailing total returns as of 4/11/2025, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: LOBEF
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: LOBEF
View MoreValuation Measures
Market Cap
4.83M
Enterprise Value
6.18M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
25.99
Price/Book (mrq)
--
Enterprise Value/Revenue
42.57
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-123.44%
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
-4.65M
Diluted EPS (ttm)
-0.0200
Balance Sheet and Cash Flow
Total Cash (mrq)
45.55k
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-1.94M